Hector Nieves-Rosado

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2026
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy.

|Jul 31, 2025
Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption.

Kristin M Morder, Madison Nguyen, Drew N Wilfahrt

|Sep 30, 2024
Tim-3 Is Required for Regulatory T Cell-Mediated Promotion of T Cell Exhaustion and Viral Persistence during Chronic Lymphocytic Choriomeningitis Virus Infection.

Hector M Nieves-Rosado, Hridesh Banerjee, Angela Gocher-Demske

|Jun 23, 2023
TIM-3 signaling contributes to the suppressive capacity of Tregs from people with HIV on antiretroviral therapy.

Hector M Nieves-Rosado, Jana L Jacobs, Asma Naqvi

Pageof 1

Frequent Collaborators

3 joint publications

Lawrence P Kane

2 joint publications

Hridesh Banerjee

2 joint publications

Bingxian Xie

2 joint publications

Benjamin M Murter